cancer

AstraZeneca, Merck win red carpet treatment at the FDA as a 3-time loser seeks speedy OK for rare tumors
Endpoints
Thu, 11/14/19 - 10:21 am
AstraZeneca
Merck
selumetinib
cancer
Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors
Fierce Biotech
Mon, 11/11/19 - 10:44 am
Bolt Biotherapeutics
immuno-oncology
clinical trials
cancer
First use of CRISPR against cancer in patients clears early safety hurdles
Stat
Wed, 11/6/19 - 10:36 am
gene editing
CRISPR
patient safety
cancer
Radius plans to cut loose oncology assets
Fierce Biotech
Wed, 11/6/19 - 10:13 am
Radius
oncology
cancer
endocrine disorders
osteoporosis
A2 Biotherapeutics emerges from stealth mode to develop tumour cell therapeutics
Pharmaceutical Business Review
Wed, 11/6/19 - 10:12 am
A2 Biotherapeutics
cell therapy
cancer
It took a 3-year struggle, but Novartis finally gets a green light on their copycat to Amgen's big blockbuster
Endpoints
Tue, 11/5/19 - 10:23 am
Novartis
FDA
Amgen
Neulasta
biosimilars
Ziextenzo
cancer
CMS proposes lifting restrictions on NGS cancer testing
Biopharma Dive
Thu, 10/31/19 - 10:39 am
CMS
next generation sequencing
diagnostics
oncology
cancer
Medicare
Sanofi axes cancer combo, early next-gen diabetes drug
Fierce Biotech
Thu, 10/31/19 - 10:09 am
Sanofi
R&D
diabetes
cancer
isatuximab
Libtayo
As Amgen zeroes in on cancer, neuroscience pipeline under the ax
Fierce Biotech
Wed, 10/30/19 - 10:20 am
Amgen
KRAS
oncology
cancer
Neuroscience
5 Biotech and Pharmaceutical Innovation Trends in 2019
BioSpace
Tue, 10/22/19 - 11:03 pm
cancer
innovation
biotech
pain management
non-opioid pain treatments
artificial intelligence
hearing aid
A change of the guard for the world’s biggest cancer companies
EP Vantage
Fri, 10/18/19 - 10:16 am
cancer
Bristol-Myers Squibb
Celgene
M&A
Roche
AstraZeneca
Mirati sets date for closely watched clinical KRAS readout
Fierce Biotech
Fri, 10/18/19 - 10:12 am
Mirati Therapeutics
KRAS
MRTX849
Amgen
cancer
Sean Parker-Backed ArsenalBio Wants To Create Better Weapons Against Cancer
Forbes
Fri, 10/18/19 - 09:41 am
ArsenalBio
precision medicine
cancer
CRISPR
Sean Parker
Helping Cancer Patients Navigate Clinical Trials
BioSpace
Tue, 10/15/19 - 10:23 pm
clinical trials
patients
cancer
Pfizer scrambles to fill void after Teva stops making chemo drug often given to children
Fierce Pharma
Tue, 10/15/19 - 10:12 pm
Pfizer
Teva Pharmaceutical
chemotherapy
cancer
pediatrics
vincristine
Forbius completes enrollment into phase 1a solid tumour trial of AVID200
Pharmaceutical Business Review
Tue, 10/15/19 - 11:01 am
Forbius
fibrosis
cancer
AVID200
solid tumors
clinical trials
Boehringer's VC wing backs anti-cancer virus startup
Fierce Biotech
Tue, 10/15/19 - 10:00 am
Abalos Therapeutics
arenavirus
Boehringer Ingelheim
cancer
Q&A: Adaptimmune’s Elliot Norry on cell therapy
Pharmaforum
Mon, 10/14/19 - 09:28 am
cell therapy
cancer
Adaptimmune
Big Pharma Bets on Body’s Garbage-Disposal System to Beat Cancer
Bloomberg
Thu, 10/10/19 - 07:55 pm
cancer
Arvinas
Kymera
targeted protein degradation
New Class of Drugs Could Help Treat Resistant Cancers
BioSpace
Mon, 10/7/19 - 11:21 pm
cancer
Institute of Cancer Research
BOS172722

Pages